CAV1 and gastric carcinoma: MicroRNA-103/107 have been identified as a invasive predictor of tumor relapse and overall survival for triple-negative breast cancer patients [65]; additionally, microRNA-103/-107 also modulated multiple drug resistance in human gastric carcinoma by downregulating caveolin-1 [66].